{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:05:20Z","timestamp":1790301920056,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut national de la sant\u00e9 et de la recherche m\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Coll\u00e8ge de France, l'Agence nationale de la recherche ANR"},{"name":"LabCom CARDIOBAPAI and Quantum Genomics"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.yjmcc.2018.12.008","type":"journal-article","created":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T20:32:22Z","timestamp":1546115542000},"page":"215-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice"],"prefix":"10.1016","volume":"127","author":[{"given":"Sol\u00e8ne Emmanuelle","family":"Boitard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Marc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Keck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Mougenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onnik","family":"Agbulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Balavoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Llorens-Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2018.12.008_bb0005","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/HYPERTENSIONAHA.107.098772","article-title":"Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension","volume":"51","author":"Bodineau","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0010","doi-asserted-by":"crossref","first-page":"86A","DOI":"10.1016\/0735-1097(93)90468-G","article-title":"Atrial natriuretic peptide in heart failure","volume":"22","author":"Brandt","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2011.00115","article-title":"Brain renin\u2013angiotensin system in hypertension, cardiac hypertrophy, and heart failure","volume":"2","author":"Campos","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0020","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/jm00044a016","article-title":"Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols","volume":"37","author":"Chauvel","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0025","first-page":"1893","article-title":"The role of BNP testing in heart failure","volume":"74","author":"Doust","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0030","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1021\/jm00091a016","article-title":"\u201cMixed inhibitor-prodrug\u201d as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes","volume":"35","author":"Fourni\u00e9-Zaluski","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0035","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1073\/pnas.0402312101","article-title":"Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension","volume":"101","author":"Fournie-Zaluski","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/CS20130396","article-title":"A new strategy for treating hypertension by blocking the activity of the brain renin\u2013angiotensin system with aminopeptidase A inhibitors","volume":"127","author":"Gao","year":"2014","journal-title":"Clin. Sci."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pbb.2014.08.010","article-title":"Alternative method of oral administration by peanut butter pellet formulation results in target engagement of BACE1 and attenuation of gavage-induced stress responses in mice","volume":"126","author":"Gonzales","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.yjmcc.2007.07.047","article-title":"Sympathetic hyperactivity and cardiac dysfunction post-MI: different impact of specific CNS versus general AT1 receptor blockade","volume":"43","author":"Huang","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/cvr\/cvs420","article-title":"Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction","volume":"97","author":"Huang","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0060","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.jacc.2004.09.044","article-title":"Impact of beta-myosin heavy chain expression on cardiac function during stress","volume":"44","author":"Krenz","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.yjmcc.2005.05.002","article-title":"Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen","volume":"39","author":"Lal","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0070","first-page":"H1786","article-title":"Brain \u201couabain\u201d and angiotensin II contribute to cardiac dysfunction after myocardial infarction","volume":"277","author":"Leenen","year":"1999","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCRESAHA.107.158261","article-title":"Brain mechanisms contributing to sympathetic hyperactivity and heart failure","volume":"101","author":"Leenen","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0080","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1186\/1755-1536-5-S1-S24","article-title":"CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis","volume":"5","author":"Lipson","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10557-012-6424-y","article-title":"RAAS inhibitors and cardiovascular protection in large scale trials","volume":"27","author":"von Lueder","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/HYPERTENSIONAHA.112.190942","article-title":"Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats","volume":"60","author":"Marc","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0095","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/HJH.0000000000001563","article-title":"Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats","volume":"36","author":"Marc","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2011.06.006","article-title":"The role of the brain renin\u2013angiotensin system in hypertension: implications for new treatment","volume":"95","author":"Marc","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0105","first-page":"803","volume":"14","author":"JJV","year":"2002","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0110","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/eurjhf\/hft052","volume":"15","author":"JJV","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0115","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1471-4159.2008.05402.x","article-title":"Human brain aminopeptidase A: biochemical properties and distribution in brain nuclei","volume":"106","author":"de Mota","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2796.2012.02517.x","article-title":"Increased interleukin-1\u03b2 levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention","volume":"272","author":"\u00d8rn","year":"2012","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0125","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0130","doi-asserted-by":"crossref","first-page":"13415","DOI":"10.1073\/pnas.96.23.13415","article-title":"Aminopeptidase A inhibitors as potential central antihypertensive agents","volume":"96","author":"Reaux","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0135","doi-asserted-by":"crossref","first-page":"29242","DOI":"10.1074\/jbc.M204406200","article-title":"Contribution of molecular modeling and site-directed mutagenesis to the identification of two structural residues, Arg-220 and Asp-227, in aminopeptidase A","volume":"277","author":"Rozenfeld","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0140","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1161\/01.CIR.89.6.2852","article-title":"Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction","volume":"89","author":"Sabbah","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-physiol-021113-170322","article-title":"Hypoxia-inducible factor 1 and cardiovascular disease","volume":"76","author":"Semenza","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"SOLVD Investigators","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2169\/internalmedicine.48.1948","volume":"48","author":"Tani","year":"2009","journal-title":"Intern. Med."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0160","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-014-0443-8","article-title":"Cardiospheres reverse adverse remodeling in chronic rat myocardial infarction: roles of soluble endoglin and Tgf-\u03b2 signaling","volume":"109","author":"Tseliou","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0165","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.RES.0000120864.21172.5A","article-title":"Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen","volume":"94","author":"Wang","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1071-9164(99)90034-9","article-title":"Left and right ventricular collagen type I\/III ratios and remodeling post-myocardial infarction","volume":"5","author":"Wei","year":"1999","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0175","doi-asserted-by":"crossref","first-page":"H423","DOI":"10.1152\/ajpheart.00685.2001","article-title":"The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure","volume":"283","author":"Zhang","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0180","doi-asserted-by":"crossref","first-page":"11968","DOI":"10.1073\/pnas.93.21.11968","article-title":"Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release","volume":"93","author":"Zini","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2018.12.008_bb0190","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0306-4522(96)00660-4","article-title":"Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats","volume":"78","author":"Zini","year":"1997","journal-title":"Neuroscience"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818307831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818307831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:26:27Z","timestamp":1758313587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818307831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":37,"alternative-id":["S0022282818307831"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.12.008","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}